59
Views
0
CrossRef citations to date
0
Altmetric
Research Article

Liquiritin Alleviates Inflammation in Lipopolysaccharide-Induced Human Corneal Epithelial Cells

ORCID Icon, , , , , , & show all
Received 02 Jan 2024, Accepted 04 May 2024, Published online: 20 May 2024

References

  • Urwin L, Okurowska K, Crowther G, Roy S, Garg P, Karunakaran E, Macneil S, Partridge LJ, Green LR, Monk PN. Corneal infection models: tools to investigate the role of biofilms in bacterial keratitis. Cells. 2020;9(11):2450. doi: 10.3390/cells9112450.
  • Ung L, Chodosh J. Foundational concepts in the biology of bacterial keratitis. Exp Eye Res. 2021;209:108647. doi: 10.1016/j.exer.2021.108647.
  • Singh RB, Das S, Chodosh J, Sharma N, Zegans ME, Kowalski RP, Jhanji V. Paradox of complex diversity: challenges in the diagnosis and management of bacterial keratitis. Prog Retin Eye Res. 2022;88:101028. doi: 10.1016/j.preteyeres.2021.101028.
  • Cabrera‐Aguas M, Khoo P, Watson SL. Infectious keratitis: a review. Clin Exp Ophthalmol. 2022;50(5):543–562. doi: 10.1111/ceo.14113.
  • Tuft S, Somerville TF, Li J-PO, Neal T, De S, Horsburgh MJ, Fothergill JL, Foulkes D, Kaye S. Bacterial keratitis: identifying the areas of clinical uncertainty. Prog Retin Eye Res. 2022;89:101031. doi: 10.1016/j.preteyeres.2021.101031.
  • Ung L, Bispo PJ, Shanbhag SS, Gilmore MS, Chodosh J. The persistent dilemma of microbial keratitis: global burden, diagnosis, and antimicrobial resistance. Surv Ophthalmol. 2019;64(3):255–271. doi: 10.1016/j.survophthal.2018.12.003.
  • Jadi PK, Sharma P, Bhogapurapu B, Roy S. Alternative therapeutic interventions: antimicrobial peptides and small molecules to treat microbial keratitis. Front Chem. 2021;9:694998. doi: 10.3389/fchem.2021.694998.
  • Yan T, Yan N, Wang P, Xia Y, Hao H, Wang G, Gonzalez FJ. Herbal drug discovery for the treatment of nonalcoholic fatty liver disease. Acta Pharm Sin B. 2020;10(1):3–18. doi: 10.1016/j.apsb.2019.11.017.
  • Yao C-L, Zhang J-Q, Li J-Y, Wei W-L, Wu S-F, Guo D-A. Traditional Chinese medicine (TCM) as a source of new anticancer drugs. Nat Prod Rep. 2021;38(9):1618–1633. doi: 10.1039/d0np00057d.
  • Huang K, Zhang P, Zhang Z, Youn JY, Wang C, Zhang H, Cai H. Traditional Chinese Medicine (TCM) in the treatment of COVID-19 and other viral infections: efficacies and mechanisms. Pharmacol Ther. 2021;225:107843. doi: 10.1016/j.pharmthera.2021.107843.
  • Fu R, Li J, Yu H, Zhang Y, Xu Z, Martin C. The Yin and Yang of traditional Chinese and Western medicine. Med Res Rev. 2021;41(6):3182–3200. doi: 10.1002/med.21793.
  • Vivero-Lopez M, Muras A, Silva D, Serro AP, Otero A, Concheiro A, Alvarez-Lorenzo C. Resveratrol-loaded hydrogel contact lenses with antioxidant and antibiofilm performance. Pharmaceutics. 2021;13(4):532. doi: 10.3390/pharmaceutics13040532.
  • Yin J, Peng X, Lin J, Zhang Y, Zhang J, Gao H, Tian X, Zhang R, Zhao G. Quercetin ameliorates Aspergillus fumigatus keratitis by inhibiting fungal growth, toll-like receptors and inflammatory cytokines. Int Immunopharmacol. 2021;93:107435. doi: 10.1016/j.intimp.2021.107435.
  • Zhu Y, Peng X, Zhang Y, Lin J, Zhao G. Baicalein protects against aspergillus fumigatus keratitis by reducing fungal load and inhibiting TSLP-induced inflammatory response. Invest Ophthalmol Vis Sci. 2021;62(6):26. doi: 10.1167/iovs.62.6.26.
  • Ren Y, Derose K, Li L, Gallucci JC, Yu J, Douglas Kinghorn A. Vincamine, from an antioxidant and a cerebral vasodilator to its anticancer potential. Bioorg Med Chem. 2023;92:117439. doi: 10.1016/j.bmc.2023.117439.
  • Tian X, Peng X, Lin J, Zhang Y, Zhan L, Yin J, Zhang R, Zhao G. Isorhamnetin ameliorates Aspergillus fumigatus keratitis by reducing fungal load, inhibiting pattern-recognition receptors and inflammatory cytokines. Invest Ophthalmol Vis Sci. 2021;62(3):38. doi: 10.1167/iovs.62.3.38.
  • Jiang M, Zhao S, Yang S, Lin X, He X, Wei X, Song Q, Li R, Fu C, Zhang J, et al. An “essential herbal medicine”—Licorice: a review of phytochemicals and its effects in combination preparations. J Ethnopharmacol. 2020;249:112439. doi: 10.1016/j.jep.2019.112439.
  • Heidari S, Mehri S, Hosseinzadeh H. The genus Glycyrrhiza (Fabaceae family) and its active constituents as protective agents against natural or chemical toxicities. Phytother Res. 2021;35(12):6552–6571. doi: 10.1002/ptr.7238.
  • Yin Y, Li Y, Jiang D, Zhang X, Gao W, Liu C. De novo biosynthesis of liquiritin in Saccharomyces cerevisiae. Acta Pharm Sin B. 2020;10(4):711–721. doi: 10.1016/j.apsb.2019.07.005.
  • Qin J, Chen J, Peng F, Sun C, Lei Y, Chen G, Li G, Yin Y, Lin Z, Wu L, et al. Pharmacological activities and pharmacokinetics of liquiritin: a review. J Ethnopharmacol. 2022;293:115257. doi: 10.1016/j.jep.2022.115257.
  • Yang X, Dang X, Zhang X, Zhao S. Liquiritin reduces lipopolysaccharide-aroused HaCaT cell inflammation damage via regulation of microRNA-31/MyD88. Int Immunopharmacol. 2021;101(Pt B):108283. doi: 10.1016/j.intimp.2021.108283.
  • Mou S-Q, Zhou Z-Y, Feng H, Zhang N, Lin Z, Aiyasiding X, Li W-J, Ding W, Liao H-H, Bian Z-Y, et al. Liquiritin attenuates lipopolysaccharides-induced cardiomyocyte injury via an AMP-activated protein kinase-dependent signaling pathway. Front Pharmacol. 2021;12:648688. doi: 10.3389/fphar.2021.648688.
  • Li X, Sun M, Long Y. Cyanidin-3-O-glucoside attenuates lipopolysaccharide-induced inflammation in human corneal epithelial cells by inducing Let-7b-5p-mediated HMGA2/PI3K/Akt pathway. Inflammation. 2020;43(3):1088–1096. doi: 10.1007/s10753-020-01194-0.
  • Li XQ, Cai LM, Liu J, Ma YL, Kong YH, Li H, Jiang M. Liquiritin suppresses UVB‑induced skin injury through prevention of inflammation, oxidative stress and apoptosis through the TLR4/MyD88/NF‑κB and MAPK/caspase signaling pathways. Int J Mol Med. 2018;42(3):1445–1459. doi: 10.3892/ijmm.2018.3720.
  • Chen H, Zhang J, Dai Y, Xu J. Nerve growth factor inhibits TLR3-induced inflammatory cascades in human corneal epithelial cells. J Inflamm (Lond)). 2019;16(1):27. doi: 10.1186/s12950-019-0232-0.
  • Xiang P, Liu RY, Li C, Gao P, Cui XY, Ma LQ. Effects of organophosphorus flame retardant TDCPP on normal human corneal epithelial cells: implications for human health. Environ Pollut. 2017;230:22–30. doi: 10.1016/j.envpol.2017.06.036.
  • Lyu F, Han F, Ge C, Mao W, Chen L, Hu H, Chen G, Lang Q, Fang C. OmicStudio: a composable bioinformatics cloud platform with real‐time feedback that can generate high‐quality graphs for publication. iMeta. 2023;2(1):e85. doi: 10.1002/imt2.85.
  • Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2 − ΔΔCT method. Methods. 2001;25(4):402–408. doi: 10.1006/meth.2001.1262.
  • Kanehisa M, Goto S. KEGG: kyoto encyclopedia of genes and genomes. Nucleic Acids Res. 2000;28(1):27–30. doi: 10.1093/nar/28.1.27.
  • Ozes ON, Mayo LD, Gustin JA, Pfeffer SR, Pfeffer LM, Donner DB. NF-κB activation by tumour necrosis factor requires the Akt serine–threonine kinase. Nature. 1999;401(6748):82–85. doi: 10.1038/43466.
  • Romashkova JA, Makarov SS. NF-κB is a target of AKT in anti-apoptotic PDGF signalling. Nature. 1999;401(6748):86–90. doi: 10.1038/43474.
  • Masterton S, Ahearne M. Mechanobiology of the corneal epithelium. Exp Eye Res. 2018;177:122–129. doi: 10.1016/j.exer.2018.08.001.
  • Chen H, Hua X-M, Ze B-C, Wang B, Wei L. The anti-inflammatory effects of asiatic acid in lipopolysaccharide-stimulated human corneal epithelial cells. Int J Ophthalmol. 2017;10(2):179–185. doi: 10.18240/ijo.2017.02.01.
  • Wang X, Quinn PJ. Lipopolysaccharide: biosynthetic pathway and structure modification. Prog Lipid Res. 2010;49(2):97–107. doi: 10.1016/j.plipres.2009.06.002.
  • Ciesielska A, Matyjek M, Kwiatkowska K. TLR4 and CD14 trafficking and its influence on LPS-induced pro-inflammatory signaling. Cell Mol Life Sci. 2021;78(4):1233–1261. doi: 10.1007/s00018-020-03656-y.
  • Thind AS, Monga I, Thakur PK, Kumari P, Dindhoria K, Krzak M, Ranson M, Ashford B. Demystifying emerging bulk RNA-Seq applications: the application and utility of bioinformatic methodology. Brief Bioinform. 2021;22(6):bbab259. doi: 10.1093/bib/bbab259.
  • Liu C, Yin Z, Feng T, Zhang M, Zhou Z, Zhou Y. An integrated network pharmacology and RNA-Seq approach for exploring the preventive effect of Lonicerae japonicae flos on LPS-induced acute lung injury. J Ethnopharmacol. 2021;264:113364. doi: 10.1016/j.jep.2020.113364.
  • Jiashuo W, Zhang F, Zhuangzhuang L, Weiyi J, Yue S. Integration strategy of network pharmacology in Traditional Chinese Medicine: a narrative review. J Tradit Chin Med. 2022;42(3):479–486. doi: 10.19852/j.cnki.jtcm.20220408.003.
  • Liu T, Zhang L, Joo D, Sun S-C. NF-κB signaling in inflammation. Signal Transduct Target Ther. 2017;2(1):17023–17023. doi: 10.1038/sigtrans.2017.23.
  • Hayden MS, Ghosh S. Shared principles in NF-κB signaling. Cell. 2008;132(3):344–362. doi: 10.1016/j.cell.2008.01.020.
  • Yu H, Lin L, Zhang Z, Zhang H, Hu H. Targeting NF-κB pathway for the therapy of diseases: mechanism and clinical study. Signal Transduct Target Ther. 2020;5(1):209. doi: 10.1038/s41392-020-00312-6.
  • Capece D, Verzella D, Flati I, Arboretto P, Cornice J, Franzoso G. NF-κB: blending metabolism, immunity, and inflammation. Trends Immunol. 2022;43(9):757–775. doi: 10.1016/j.it.2022.07.004.
  • Manning BD, Toker A. AKT/PKB signaling: navigating the network. Cell. 2017;169(3):381–405. doi: 10.1016/j.cell.2017.04.001.
  • Chen K, Li Y, Zhang X, Ullah R, Tong J, Shen Y. The role of the PI3K/AKT signalling pathway in the corneal epithelium: recent updates. Cell Death Dis. 2022;13(5):513. doi: 10.1038/s41419-022-04963-x.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.